Naproxcinod | Interleukin Related interleukin-related.com

Product Name :
Naproxcinod

Search keywords :
Naproxcinod

drugId :
null

Target Vo:
Cyclooxygenase-2

Target Vo Short Name :
COX-2

Moa_Name:
Cyclooxygenase-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nicox

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Liver Diseases

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AMPK alpha 2(S345) Rabbit mAb Biological Activity
Pivekimab Technical Information
MTNR1A Antibody: MTNR1A Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-MTNR1A polyclonal antibody. MTNR1A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep, guinea pig background without labeling.

Author: Interleukin Related

Related Posts